Media News

First Day Closed at HK$5.36 HONG KONG, July 12, 2022 /PRNewswire/ -- With a leading position in the medical products and channels segment, mainly providing healthcare insight solutions via offline channels to address the sales and marketing needs of the medical product manufacturer clients. - Sinohealth Holdings Limited ("Sinohealth Holdings" or the "Company", stock code: 2361.HK, together with its subsidiaries,...

SYDNEY, July 12, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the launch of its Scientific Advisory Board (SAB). The new SAB consists of four distinguished clinicians and scientists with expertise in the development of innovative therapies for brain cancer. Key...

- The first GMP certificate that WuXi Vaccines has received from the regulatory agency - A critical step for WuXi Vaccines to enable the manufacturing of commercial vaccine products in its Dundalk facility and supplying the global market for a top-10 pharmaceutical company DUNDALK, Ireland, July 12, 2022 /PRNewswire/ -- WuXi Vaccines, a global leading vaccines Contract Development and...

Manufacturers should focus on higher bioavailability ingredients and innovation says, Frost & Sullivan SAN ANTONIO, July 12, 2022 /PRNewswire/ -- The need for higher bioavailability ingredients spurs innovation in the bone and joint health ingredients market, finds Frost & Sullivan's recent analysis, Global Bone and Joint Health Ingredients Industry. The increasing geriatric population and the incidence of bone and joint...

Shows potent and rapid antibacterial activity against clinical isolates in Europe and Korea both CDL200,  a novel endolysin pipeline for the treatment of Clostridioides difficile Infection (CDI) The world's first endolysin in capsule formulation to be administered orally BOSTON and SEOUL, South Korea, July 12, 2022 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) announced today that CDL200, a...

Bringing Diverse Expertise With Unified Approach To Eliminate Poor Vision In A Generation DALLAS, July 12, 2022 /PRNewswire/ -- The Vision Impact Institute has announced it is joining the OneSight EssilorLuxottica Foundation. Its current staff and assets will form the Advocacy and Global Partnerships focus area of the OneSight EssilorLuxottica Foundation,...

SALT LAKE CITY, July 11, 2022 /PRNewswire/ -- Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the acquisition of Dependable Plastics and creation of a new division -- Biomerics Interventional Medical Plastics (IMP) Division. Biomerics' IMP Division with operations in Fairfield, California, and Salt Lake...

Agreement will provide the first protein-based vaccine option in the U.S., pending FDA Emergency Use Authorization and CDC recommendation GAITHERSBURG, Md., July 11, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced an agreement with the...

Aims to build an eco-friendly business environment and achieve net zero GHG emissions in its operations, moving towards 100% renewable energy. Details new social contribution activities that strives to support the health of its local communities. Requires commitment to the Supplier Code of Conduct, enhanced in accordance with RBA and PSCI. Establishes increased independence and transparency in its...

New KonsultaMD superapp to be one-stop-shop for all health services; Creates largest PH healthtech play MANILA, Philippines, July 11, 2022 /PRNewswire/ --  Three Philippine companies have come together to deliver the largest healthtech play in the country, aiming to provide accessible healthcare to Filipinos through a one-stop health superapp. Globe Capital Venture Holdings, Inc. (917Ventures), the corporate venture builder...